The study compared patients who died in-hospital to those who survived to discharge in a cohort of 93 patients meeting strict definitions for CS to identify correlates associated with mortality. Results: The overall in-hospital mortality rate for the study cohort was 33%. The baseline characteristics were balanced except for older average age and left ventricular ejection fraction in those who died (pϭ0.049 and pϭ0.014, respectively). As detailed in the Table, the insertion of IABP pre-PCI, cardiac arrest at the catheterization lab, and lower ejection fraction (EF) were all correlated with in-hospital mortally (odd ratios 2.68, 5.93 and 0.02, respectively). Conclusions: In the era of PPCI and IABP as standard of care in AMI complicated by CS, patients with low EF, those who necessitate IABP insertion pre-PCI and those who necessitated CPR during PCI are at higher risk for in-hospital mortality and should be considered for more robust devices (e.g. assisted devices) with an attempt to improve their prognosis.
were compared to those with MVD (nϭ118) and predictors of MVD disease were evaluated using multiple logistic regression analysis.
Results: Patients with MVD had a higher prevalence of hypertension, hyperlipidemia, diabetes mellitus, metabolic syndrome and a family history of CAD compared to those with SVD. The left anterior descending artery was more commonly the infarct related artery in patients with SVD compared to the right coronary artery in patients with MVD.
In-hospital MACE rates were significantly higher in patients with MVD compared to those with SVD, 30.5% versus 17.9%, p 0.03, respectively. Hyperlipidemia, hypertension, diabetes mellitus, total ST segment changes Ͼ 6 mm and total number of ECG leads with Ͼ 1 mm ST segment depression predicted the presence of MVD. After adjusting for age and gender, more than 3 ECG leads with Ͼ 1 mm of ST segment depression predicted the presence of MVD, odds radio 3.79 (95% CI 1.2 to 12.3, p 0.03).
Conclusions: STEMI patients with MVD can be identified based upon the initial ECG. Background: Increased oxidative stress and vascular inflammation are main mechanisms for no reflow onset after acute ST-segment elevation myocardial infarction(STEMI) who were treated by primary percutaneous coronary intervention (PCI). Recent studies have been reported that the concentration of total bilirubin (TB), acted as antioxidant, could preserve coronary flow reserve and coronary microvascular functions and was reversely associated with in hospital outcomes of primary PCI. However, it is not clear whether high TB exert favorable effects on prognosis of no reflow patients during PCI. This study was performed to assess the prognostic role of TB in no reflow patients. Material and Methods: 143 consecutive patients (age: 65.29Ϯ12.62 years old) with no reflow treated by primary PCI was enrolled to study. Patients were divided into two groups based on the TB concentrations (0.9 mg/dl). No-reflow was diagnosed using 2 different methods after PCI: TIMI flow GradeՅ2 or TIMI flow grade 3 with a TIMI myocardial perfusion grade(TMPG)Յ1. All patients were retrospectively followed up for 9 years for the all cause death and cardiac death.
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Results: There were 31 all cause deaths during follow-up. Of them, 26 patients died from cardiac cause. Patients with adverse events had lower baseline serum TB levels (PϽ0.05). All patients were stratified into high TB and low TB groups. The mortality of 
